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ABSTRACT 
STATEMENT OF THE PROBLEM 
“A Study to Assess the Effectiveness of Pomegranate Popsicles on 
Inflammation of the oral mucosa among Patients on Chemotherapy in a 
Selected Hospital at Chennai.” 
OBJECTIVES OF THE STUDY 
 To evaluate the effectiveness of pomegranate popsicles on oral 
mucositis among patients receiving chemotherapy in experimental 
and control group.  
 To find out the association between the post-test level of oral 
mucositis among patients receiving chemotherapy with their 
selected demographic variables. 
METHODS 
A Quantitative Research approach was adopted for this study. A 
review of literature was done on studies related to oral mucositis as a 
side effect of chemotherapy, studies related to the prevention of oral 
mucositis by cryotherapy and studies related to pomegranate and its effect 
on cancer. The conceptual framework opted for this study was based on 
the Model of Widenbach‟s helping art of clinical nursing theory (1969), 
in order to achieve the objectives of the study. The Research design 
adopted was post test only control group design. The tool adopted  for 
the study is standardized “WHO Oral Mucositis Scale”. The tool was 
validated by 5 experts. 
 A pilot study was conducted before under taking the main study. 
The main study was conducted in Dr.Kamakshi Memorial Hospital 
Pvt.Ltd., Radial Road, Pallikaranai, Chennai, among 60 samples of first 
cycle chemotherapy patients. Purposive sampling technique was used to 
  
select 30 samples into experimental group and 30 patients into control 
group. The study lasted for a period of 4 weeks during which, the first 
and second weeks subjects were taken as experimental group and in the 
third and fourth weeks subjects were taken as control group.  
Demographic data was collected from the subjects. Intervention with 
pomegranate popsicles was given to the experimental group whereas the 
control group followed the routine mouth was with fresh water three 
times a day. And post test level or oral mucositis was assessed on the 
seventh day. The data was analysed by descriptive and inferential 
statistics, the hypothesis was tested, the objectives were achieved and 
the result was presented. 
MAJOR FINDINGS OF THE STUDY 
The findings of the study revealed the analysis post test scores of 
oral mucositis level on first cycle chemotherapy patients. The analysis 
revealed that in experimental group 23 (77%) of them did not develop 
oral mucositis, 7 (23%) of them had mild level of oral mucosits and 
none of them had moderate, severe or intravenous feeding level of oral 
mucositis. In control group none of the patients had sever or intravenous 
feeding level of oral musocitis, 6 (20%) of them had moderate level of 
oral mucositis, 7 (23%) of them had mild oral mucosits and 17 (57%) of 
patients did not develop oral mcositis.  
In the experimental group the mean score of oral mucositis is 0.23 
and Standard Deviation 0.430. In the control group the mean score of 
oral mucositis is 0.63 and Standard Deviation 0.809. The paired  „t‟ test 
gave a „t‟ value of 2.392, at df=58, the p value was 0.020019 which is 
significant at p < 0.05 level. Therefore pomegranate popsicles proved to 
have a significant effect on preventing inflammation of the oral mucosa 
among chemotherapy patients. 
  
Among chemotherapy patients the demographic variables such as, 
Age, Sex, Educational Status, Occupation, Type of Activity, etc. had no 
significant association with post test oral mucositis level, whereas what 
the patient used for brushing and the use of chat items in the diet 
showed to have a significant association with post test level of oral 
mucositis at p < 0.05 level.  
CONCLUSION 
This study assessed the effectiveness of pomegranate popsicles on 
oral mucositis induced by chemotherapy.  From the results of the study, 
patients who were intervened with pomegranate popsicles were 20% less 
likely to develop oral mucositis. 
Thus nurses can give pomegranate popsicles to patients 
undergoing chemotherapy to reduce oral mucositis induced by 
chemotherapy as it is, one of the best, non-pharmacological and cost 
effective intervention proved to reduce oral mucotitis among 
chemotherapy patients. 
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CHAPTER – I 
INTRODUCTION 
“An ounce of prevention is worth a pound of cure.” 
- (Benjamin Franklin) 
"We live in a super-fast age where the Internet has shrunk the 
world dramatically and people are connected 24×7. Multitasking is the 
order of the day and we struggle to fulfill our responsibilities to our 
employers, parents, spouses, children, clients and many others. In this 
melee, we too often forget to spare time to take care of our health.  
Health is one of the most important assets we human beings have, it 
permits us to fully develop our capabilities and live our lives to the 
fullest. If this asset erodes or is not taken care of, it can cause physical 
and emotional weakening and be an obstacle in the lives of people.  
Our altered lifestyle habits make us vulnerable to many diseases 
like obesity, diabetes, hypertension, heart disease, cancer, and stroke. 
Among the many diseases which deteriorate health, cancer has a 
prominent place. The patient's prognosis, treatment modalities and side 
effects of treatment for cancer are long-lasting issues that can severely 
affect a person‟s quality of life.  
                   According to the Data gathered for the Leading 
Causes of Death by the Centers for Disease Control and Prevention  in 
2011, cancer has got the second place for the world‟s leading cause of 
death. There were an estimated 14.1 million cancer cases around the 
world in the year 2012, of these 7.4 million cases were in men and 6.7 
million cases in women. This number is expected to increase to 24 
million by 2035. This growing cancer burden was a key focus of the 
United Nations General Assembly High-Level Meeting on Non-
Communicable Diseases on September 2011 in New York.  
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A person diagnosed with cancer may undergo surgery, radiation or 
chemotherapy as a management of cancer, among which chemotherapy 
is the commonest treatment modality. It controls the uncontrolled 
division of cells by interfering with cellular function and reproduction. 
Chemotherapy is used to reduce tumour size preoperatively, to destroy 
any remaining tumour cells postoperatively, or to treat some forms of 
leukaemia. Cells with rapid growth rates such as bone marrow, 
epithelium, hair follicles and sperm are very vulnerable to damage due 
to chemotherapy.  
The rapid proliferation rate of epithelial lining of oral cavity 
makes it susceptible to the effect of chemotherapy resulting in oral 
mucositis. Oral complications that arise with chemotherapy and/or 
radiation therapy include xerostomia (dry mouth), dental caries, loss of 
taste, osteoradionecrosis, oral mucositis and bacterial, fungal, or viral 
infection mainly in neutropenia patients. Among these oral mucositis is 
a major nonhematologic complication of cytotoxic chemotherapy and 
radiotherapy associated with significant pain, dyseugia, 
odynodysphagia, subsequent dehydration and malnutrition. 
Although the exact pathophysiology of mucositis may not be fully 
elucidated, it is thought to have two main mechanisms: direct mucositis 
and indirect mucositis, caused by chemotherapy and/or radiation 
therapy. 
Direct Mucositis - The epithelial cells of the oral mucosa undergo rapid 
turnover every 7 to 14 days, making these cells susceptible to effects of 
cytotoxic therapy. Both chemotherapy and radiation therapy can 
interfere with the maturity and growth of epithelial cells, causing 
changes in normal turnover and cell death.  
 3 
 
Indirect Mucositis - It is caused by indirect invasion of gram-
negative bacteria or fungal species. Patients are usually at increased risk 
for oral infections when they are neutropenic. The onset of oral 
mucositis secondary to myelosuppression varies, depending on the 
timing of neutrophil count associated with the chemotherapy agent 
administered, but typically develops anywhere around 10 to 21 days 
after chemotherapy. 
Cancer patients who are undergoing chemotherapy usually show 
signs of mucositis four to five days after beginning of treatment , 
reaching a peak around 7
th
 day to 10
th
 day, and then slowly improving 
over the course of a few weeks. As a result of cell death in reaction to 
chemotherapy or radio-therapy, the mucosal lining of the mouth 
becomes thin, slough off, then become red, inflamed and ulcerated. The 
ulcers become covered by a yellowish white fibrin clot called a pseudo 
membrane.
 
These ulcers may range from a size of 0.5 cm to greater than 
4 cm.  
Oral mucositis can be severely painful related to the extent of the 
tissue damage. The pain is often described as a burning sensation 
accompanied by reddening. The patient may experience trouble in 
speaking, eating, or even opening the mouth because of pain. An 
alteration in taste perception (dysgeusiaor) is commonly noted, 
especially for those who are receiving a concomitant radiation therapy 
to the neck and mouth area. Taste blindness or an altered sense of taste, 
is a temporary condition that occurs because of effects on taste buds that 
are mostly located in the tongue. Sometimes, only a partial recovery of 
taste occurs. Common complaints include, food tasting too sweet or too 
bitter or having a continuous metallic taste.   
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Many preventive measures which are directed towards aetiology 
of oral mucositis have been currently gaining importance. Preventing a 
complication beforehand is much easier and less costly than treating it. 
In this context, cryotherapy (oral cooling using ice) has become a cheap 
and readily applicable method in preventing or decreasing oral mucositis 
developing due to chemotherapy. Cryotherapy causes a local 
vasoconstriction, which in turn reduces blood flow in oral mucosa and 
reduces the amount of drug distributed to cells, thereby reducing the 
incidence of oral mucositis. 
               In conclusion, severe oral mucositis is a common cause 
of morbidity in patients undergoing chemotherapy. It may be further 
complicated by an infection or bleeding and it becomes more difficult 
for patients to maintain their oral hygiene. Higher symptoms burden will 
have a profound impact on patient‟s quality of life and level of 
psychological distress. For minimizing the symptoms of oral mucositis 
applying oral ice cubes is a cheap, readily applicable and effective 
method. 
 
1.1 NEED FOR THE STUDY 
                Projections based on Global Burden of Cancer Study 
(GLOBOCAN) 2012 estimates predict a substantive increase to 19.3 
million new cancer cases per year by 2025, due to the rapid growth and 
ageing of the global population. More than half of all cancers (56.8%) 
and cancer deaths (64.9%) in 2012 occurred in less developed regions of 
the world, and these proportions will increase further by 2025.  
                In the Indian scenario, Cancer is the second most 
common disease in India responsible for maximum mortality with about 
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0.3 million deaths per year. This is owing to the poor availability of 
prevention, diagnosis and treatment of the disease.  GLOBOCAN 2012 
estimates 1.1 million new cancer cases, indicating India as a single 
country (of the 184 countries) contributing to 7.8% of the global cancer 
burden; mortality figures were 682830, contributing to 8.33% of global 
cancer deaths; and the five year prevalence was 1.8 million individuals 
with cancer corresponding to 5.52% of global prevalence. As per Indian 
population census data, the rate of mortality due to cancer in India was 
high and alarming with about 806000 existing cases by the end of the 
last century. 
                In Tamil Nadu, projections from a cross sectional study 
carried out by Selvaraj J et al 2014 exploring the patterns and trends of 
the cancer incidences in the western regions including Coimbatore, 
Erode, Tiruppur, Salem, Namakkal and Nilgiris confirms that cancer is 
an important cause of adult deaths. The cancer cases were segregated 
district-wise for specific cancer sites and the age-standardized incident 
rates were calculated for different age groups. More than 70% of fatal 
cancers occurred during the productive ages of 50-74 years of age. 
Among all districts in Tamil Nadu, the highest frequency of cancer cases 
was observed in Coimbatore district and least in Nilgiris district.  
                In Chennai, the total cancer burden is predicted to 
increase up to 32% by 2012–16 compared with 2002–06, with 19% due 
to changes in cancer risk and further 13% due to the impact of 
demographic changes, states a research carried out by R. Swaminathan 
et al 2011 of the Division of Epidemiology and Cancer Registry, Cancer 
Institute (WIA), Chennai. The annual cancer burden predicted for 2012 –
16 is 6100 for Chennai, translating to 55,000 new cancer cases per year 
statewide in Tamil Nadu. 
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       Dr.Kamakshi Memorial Hospital a Super speciality hospital 
providing services to all the divisions of health care including cancer 
care pioneered not only in advanced scientific management of d iseases 
but also in equipping with modern technologically advanced Gadgets. 
Their success rates are comparable to the best centers in the world. 
According to the hospital statistics 2648 patients have been treated for 
cancer in 2013, out of which 24% of patients underwent radiation 
therapy, 60% of patients underwent chemotherapy, and 16% of patients 
underwent brachytherapy. The statistics showed a similar trend with 
majority of the patients on chemotherapy the year following also.  
      Statistics from Cancer Treatment and Survivorship Facts 
and Figures 2012-2013 shows that 31% of Breast Cancer patients 
undergo chemotherapy, 50% of Colon Cancer patients undrgo 
chemotherapy, 62% of Rectal Cancer patients undergo chemotherapy 
and 20% Non-Small Cell Lung Cancer patients are undergoing 
chemotherapy. Similarly in Testicular Germ Cell Tumor patients 67% 
are undergoing chemotherapy and in Uterine Cancer 33% are on 
chemotherapy. Chemotherapy alone, or in combination with radiation, is 
often given to patients with advanced stage of the disease. 
      Oral mucositis is one of the most common adverse reactions 
encountered in chemotherapy as well as in, radiation therapy for head 
and neck cancers, and is often debilitating.  It may even limit the 
patient's ability to tolerate chemotherapy or radiation therapy, as the 
nutritional status of the patient is compromised. It may drastically affect 
the cancer treatment as well as patient's quality of life. The incidence 
and severity of oral mucositis will vary from patient to pat ient. It will 
also vary from treatment to treatment.  
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     According to an US Oncological Review on Chemotherapy-
induced Oral Mucositis by Raj Sadasivan 2010 the incidence of oral 
mucositis in cancer patients varies widely. In patients receiving high-
dose of myeloablative chemotherapy, the incidence rate of oral 
mucositis is nearly 100%. The incidence rate is also high in patients 
undergoing head and neck cancer treatments; especially if they are 
receiving concurrent chemoradiotherapy the incidence rate of o ral 
mucositis may be as high as 90%. In general, the incidence rate of oral 
mucositis in cancer patients undergoing chemotherapy at standard doses 
is 40–60%. In patients undergoing chemotherapy at standard doses, oral 
mucositis generally presents itself as grades 1 and 2 rather than grades 3 
and 4. Even with these early grade presentations, patients usually will 
often not report it to their physicians or to their family members. 
Patients can rapidly become dehydrated, malnourished and deteriorate to 
the severity of needing hospitalization. It was noted that 16% of patients 
with oral mucositis developed due to chemotherapy required 
hospitalization. 
       Oral mucositis can lead to septicemia, bacteremia and 
fungemia when the patient is in neutropenia. Early diagnosis could lead 
to a change in the schedule of treatment and alleviating mucositis and its 
complications. These findings have created a broader understanding of 
oral mucositis and the need to treat it early in its presentation, rather 
than leaving it as an unmet medical need. Thus assessing the nature of 
oral mucositis becomes essential among patients receiving 
chemotherapy. 
         Cryotherapy is an inexpensive and readily available 
treatment for oral mucositis. Studies evaluating cryotherapy noted 
benefits in patients who chewed on ice before each chemotherapy 
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infusion. The incidence of oral mucositis and the degree of oral 
mucositis (incidence of grade 3 and 4) were mildly diminished with 
cryotherapy.  
         In a comparative study by Sue Nikoletti et al 2005 on plain 
ice and flavoured ice for preventing oral mucositis associated with use 
of chemotherapy. Findings from 67 patients revealed that when 
participants used standard care alone, they were significantly more 
likely to experience symptoms of oral mucositis than when they used 
either plain or flavoured ice. Odds ratios were at least threefold higher 
for standard care alone, varying according to the instrument used. The 
two main concerns reported were the taste of flavoured ice and the time 
required to complete the cryotherapy interventions. Side effects such as 
nausea, sensitivity and headache were reported more frequently for 
flavoured ice. The study recommended further research with 
unsweetened fruit juices to see effectiveness.  
        In a randomised controlled trial by Svanberg A et al 2010 to 
investigate if oral cryotherapy during chemotherapy reduces oral 
mucositis and improves nutrition. There were significantly fewer 
patients in the experimental group with oral mucositis grade 3-4 than in 
the control group and significantly lower number of days in the hospital. 
No significant difference could be found with regard to infection rate. 
Oral cryotherapy reduced oral mucositis, number of hospital days, and 
the need for total parenteral nutrition and resulted in a better nutritional 
status of the patient. 
       A study conducted by Castelino Flavia et al 2011 focusing 
on prevention of oral mucositis among cancer patients receiving 
chemotherapy using plain versus flavored ice cubes to improve their 
quality of life with fewer complications. The check list scores of the 
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patients showed that there is a difference in the experiences of the 
patients while sucking plain ice cubes and flavored ice cubes. As a 
whole the results showed that the flavored ice cubes were effective in 
preventing mucositis and the patients were in favor of the flavored ice 
cubes. 
            At present there is no standard precaution to prevent or 
treat oral mucositis developed as a side effect of cancer management and 
no intervention is completely successful at preventing or treating oral 
mucositis. The several solutions, drugs and methods used and studied in 
the prophylaxis and therapy of chemotherapy or radiotherapy-induced 
oral mucositis reflects the need of new, more efficient tools in the 
management of this complication. Current studies and our increasing 
understanding of the etiology and pathogenesis of oral mucositis will 
lead to new approaches to the management and improved quality of life 
for these patients. 
            Further intensive research through well-structured clinical 
trials to obtain the best scientific evidence over the standard therapy for 
oral mucositis is necessary to attain ideal parameters for radiotherapy 
and chemotherapy. The above literatures and the recommendation for 
further research with frozen fruit juices motivated the investigator to 
undertake this study. As ice cubes can be made readily available and 
cheaper, people undergoing chemotherapy may effectively use this in 
their due course of therapy. Keeping the above views in mind the 
investigator had an intense curiosity to assess the effectiveness 
pomegranate popsicles over oral mucositis among the pat ients receiving 
chemotherapy    
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1.2 STATEMENT OF THE PROBLEM 
A Study to assess the Effectiveness of Pomegranate Popsicles on 
Inflammation of the oral mucosa among Patients on Chemotherapy in a 
Selected Hospital at Chennai. 
1.3 OBJECTIVES OF THE STUDY 
 To evaluate the effectiveness of pomegranate popsicles on oral 
mucositis among patients receiving chemotherapy in experimental 
and control group.  
 To find out the association between the post-test level of oral 
mucositis among patients receiving chemotherapy with their 
selected demographic variables. 
1.4 OPERATIONAL DEFINITIONS 
Effectiveness: Refers to the reduction in the occurrence or 
absence of oral mucositis as assessed by using W.H.O scale for 
assessing oral mucositis after the administration of Pomegranate 
Popsicles.”. 
Pomegranate Popsicles: Refers to the fresh frozen pomegranate 
(Punica granatum – Ruby variety) juice cubes with a length 4cm, width 
2.5cm, height 3cm, surface area 59cm
2
, volume 30cm
3
 equivalent to 
10ml with smooth corners and a 7cm ice-cream stick to hold. 
Inflammation of the oral mucosa: Refers to the soreness or 
erythema of oral mucosa occurring as a side effect of chemotherapy 
which can be assessed using W.H.O scale for assessing mucositis scale.   
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Patient: Refers to both male and female subjects in the age group 
of 30-60 years, who being diagnosed with cancer (excluding oral 
cancer), and are undergoing first cycle chemotherapy.  
Chemotherapy: Refers to the use of drug therapy with drugs like 
(etoposide, platinol, mitomycin and vinblastin) to treat patients 
diagnosed with cancer. 
1.5 RESEARCH HYPOTHESIS 
H1:  There is a significant difference in the post-test levels of 
inflammation on the oral mucosa among patients on chemotherapy 
between experimental and control group.  
H2:  There is a significant association between the post-test levels of 
inflammation of the oral mucosa among patients on chemotherapy 
with their selected demographic variables.  
1.6 ASSUMPTIONS 
1)  The patients receiving chemotherapy may develop inflammation 
of the oral mucosa as its side effect.  
2)  Using Pomegranate Popsicles application is non pharmacological 
measure of preventing inflammation of the oral mucosa among 
patients on chemotherapy. 
3)  Oral cooling reduces the distribution of the chemotherapeutic 
agents to the oral mucosa by causing vasoconstriction.   
1.7 DELIMITATIONS 
1)  Study limited for 4 weeks 
2)  Limited to only patients on first cycle chemotherapy.  
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CHAPTER – II 
2.1 REVIEW OF LITERATURE 
Reviewing of literature was an essential component of the 
research study as it provides a broad understanding of the research 
problem. A review of related literature involves the systemic 
identification, location scrutiny and summary of written materials that 
contain information on research problems (Polit and Hungler 1998). 
Keeping this in mind the investigator probed into the accessible sources 
and gained in depth understanding from the related studies. It gives a 
theoretical base for the research and helps to determine the nature of 
research. 
Literature relevant to the present study was mentioned under the 
following headings: 
PART – I: LITERATURE RELATED TO 
1) Studies related to oral mucositis as a side effect of cancer. 
2) Studies related to the prevention of oral mucositis by cryotherapy 
condition. 
3) Studies related to pomegranate and its effect on cancer .  
1. Studies related to oral mucositis as a side effect of cancer . 
Cheng KK et al (2012) A multicenter study was conducted to 
characterize the range of oral symptoms and affect upon quality of life 
reported by patients in relation to the severity of oral mucositis and 
symptom burden during chemotherapy. The study  included a total of 
140 patients undergoing chemotherapy. Participants completed the self -
report Mouth and Throat Soreness-related Questions of the Oral 
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Mucositis Daily Questionnaire (OMDQ) for 14 days and the Oral 
Mucositis-specific Quality of Life Measure (OMQoL) at baseline, day 7, 
and day 14. The incidences of non-severe and severe mucositis were 
23% (n = 32) and 18% (n = 25), respectively. The symptoms reported by 
the patients with oral mucositis were related to eating (82.4%), 
swallowing (78.9%), drinking (75.4%), sleeping (71.9%), and talking 
(43.9%). Approximately 39% (22 out of 57) of patients with mucositis 
reported at least two simultaneous symptoms resulting from oral 
mucositis. About a quarter of them (25%, 14 out of 57) reported having 
all five symptoms concurrently. The study concluded that severe oral 
mucositis is a common cause of morbidity in patients undergoing 
chemotherapy. High-symptom burden due to oral mucositis may have 
profound impacts on patient quality of life and levels of psychological 
distress. 
Naima Otmani et al (2011) A prospective study was conducted to 
analyse the incidence and to determine the severity of oral mucositis 
(OM) in cancer patients. Patients with malignant disease treated by 
chemotherapy between January 2001 and December 2006 were recorded. 
Patients (n = 970) with malignant disease were studied. The result 
showed that OM occurred in 540 (55.6%) patients, and 17.9% of them 
encountered severe grades. Mean time of onset of the lesions was 10.5  
± 6.8 (range, 1-22 days) and mean duration was 6.8 ± 3.1 (range, 
2-23 days). The study concluded that underlying disease and 
chemotherapy regimens are the principal risk factors of OM 
development. 
Raber-Durlacher JE et al (2010) A study was conducted to 
assess the Oral mucosal damage which is the side ef fect of radiotherapy 
and chemotherapy treatment for cancer. The samples of 60 patients were 
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selected. Oral mucositis prevalence, risk factors, clinical and economic 
impacts, etiology, and clinical management in view of the most recent 
evidence. With prevalence between 10% and 100%, depending on the 
cytotoxic and/or radiotherapy regimen and patient-associated variables, 
this morbid condition represents a significant problem in oncology. The 
result of the study was despitly clear progress and the development of 
clinical guidelines on this topic, what currently have to offer to patients 
to manage mucositis and oropharyngeal pain is still inadequate. The 
study concluded that Expansion of the knowledge of the pathogenesis of 
mucositis as well as a better insight into individual risk factors will 
provide opportunities to improve management strategies.  
Linda S Elting et al (2008) A prospective study was conducted to 
assess the demonstration of the frequency, severity, resistance to 
palliation and impact on quality of life of adolescent patients.  A sample 
of 126 patients with head and neck cancer were prospectively estimated. 
A validated, patient-reported questionnaire on oral mucositis daily 
questionnaire, quality of life (QOL), and the Functional Assessment of 
Chronic Illness Therapy (FACIT) and fatigue scales were used to 
measure mucositis (reported as mouth and throat soreness), daily 
functioning, and use of analgesics. The study showed that risk of 
mucositis was virtually identical in the 126 patients with oral cavity or 
oropharynx tumors (99% overall; 85% grade 3-4) compared with 65 
patients with tumors of the larynx or hypo pharynx (98% overall; 77% 
grade 3-4). The mean QOL score decreased significantly during RT, 
from 85.1% at baseline to 69.0% at sixth week, corresponding with the 
peak of mucositis severity. The study concluded that Mucositis occurs 
virtually among all patients who are undergoing radiation treatment with 
chemotherapy for head and neck cancers. The detrimental effects on 
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QOL and functional status are significant, and opioid analgesia provides 
inadequate relief. 
Karen L. Syrjala et al (2004) A study is to estimate the impact 
of oral mucositis and its sequelae on health-related quality of life 
(HRQOL) and develop a daily diary measure of mucositis-related 
HRQOL in patients receiving mucotoxic cancer therapy. Two focus 
groups were conducted with patients who were suffering or had suffered 
from mucositis as a result of mucotoxic cancer therapy. Forty-seven 
patients receiving hematopoietic stem cell transplantation or treatment 
for stage III or IV colorectal cancer or head and neck cancer completed 
the daily diary questionnaire, along with other ratings of functional 
activity. The study concluded that Oral mucositis afflicts 40%–70% of 
patients who receive conventional chemotherapy or radiation treatment. 
Hematopoietic stem cell transplant recipients have a mucositis rate of 
over 90%. Despite the frequency of severe oral mucositis in these 
patients, little attention has been given to its effects on their  functioning 
and well-being or HRQOL 
2. Studies related to the prevention of oral mucositis by cryotherapy.
  
Roham Salek (2012) A randomized controlled trial assessing the 
effect of oral cryotherapy on the incidence and severity of 
chemotherapy-induced oral mucositis in combined chemotherapy 
regimens in 80 cancer patients. Patients were divided into two groups, 
experimental and control. The experimental group was given ice to place 
in their mouths from 5 min before to 5 min after chemotherapy. The 
control group received no intervention. According to the WHO based 
Oral Mucositis Scale, the incidence of oral mucositis in the intervention 
group (45%) was significantly lower than the control group (77.5%; 
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P=0.01). The incidence of oral mucositis in the intervent ion group based 
on the Patient-Judged Oral Mucositis Scale was lower than the control 
group. The findings of this study indicated that patients who underwent 
cryotherapy had less severe oral mucositis based on both WHO (P=0.01) 
and patient oral mucositis scales (P=0.001). The study concluded that, 
oral cryotherapy because of its ease of application, tolerability and lack 
of side effects makes it an important resource for reducing the incidence 
and severity of oral mucositis.  
    Katranci, N et al (2012) A randomized controlled trial with 
random assignments to the experimental and control groups, was 
conducted with cancer patients. The study included 60 patients; 30 
patients in the study group were instructed to hold ice cubes in their 
mouth shortly before, during, and shortly after infusion of 5-FU with 
leucovorin, the 30 patients in the control group received routine care. 
Oral mucositis in the patients was evaluated at 7, 14, and 21 days after 
chemotherapy. For analysis of data, chi-square, Fisher's tests were used; 
p < 0.05 was accepted as statistically significant.  In the majority of 
patients receiving cryotherapy, oral mucositis was not observed (Grade 
0) at 7 and 14 days. Similarly, incidence of Grades 1, 2, and 3 oral 
mucositis in the experimental group was quite a bit lower when 
compared to the control group (p < 0.05). On day 21, no statistically 
significant difference between the experimental and control groups was 
determined based on the development of oral mucositis (p > 0.05). Its 
found that oral cryotherapy has a significant contribution to the 
protection of oral health by reducing mucositis score according to the 
WHO mucositis scale, especially on the 7th and 14th days. Nurses' 
awareness of how cryotherapy can affect patients and options for 
resolving problems will enable them to provide a higher standard of 
individualized care. 
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   Castelino Flavia, Devi Elsa Sanatombi, Jyothi R K, (2011) A 
study focusing on prevention of mucositis among cancer patients 
receiving chemotherapy using plain versus flavored ice cubes to care 
their pain and improve their quality of life with fewer complications. 
The objectives of the study were to assess the oral mucosa before and 
after the treatment, to identify the experiences of patients during the 
therapy while sucking the ice cubes and compare the effectiveness of 
plain ice cubes versus flavored ice cubes in preventing oral mucositis. 
An experimental approach with Cross- over Design was adopted to 
identify the difference in the effectiveness of the treatments in both  the 
groups. The maximum (14) number (66.9%) of patients were in the age 
group of 34–65 years, thirteen (59.1%) were males, all 22 (100%) of 
them were suffering with cancer of the Gastro Intestinal tract. The 
majority 15 (68.2%) have received injection 5-FU with Leucovorin, 
Twenty (91%) were diagnosed to have cancer since 1–12 month 
duration, and Nineteen (86.4%) of them were operated once. The check 
list scores of the patients showed that there is a difference in the 
experiences of the patients while sucking plain ice cubes and flavored 
ice cubes. As a whole the results showed that the flavored ice cubes 
were effective in preventing mucositis and the patients were in favor of 
the flavored ice cubes. 
  Svanberg A et al (2010) A study to investigate if oral 
cryotherapy during myeloablative therapy may influence frequency and 
severity of mucositis. A stratified randomisation was used. Mucositis 
was measured on WHO mucositis scale. Number of days of total 
parenteral nutrition, infection rate, weight, albumin levels and days at 
hospital was compared. There were significantly fewer patients in the 
experimental group with mucositis grade 3-4 than in the control group 
and significantly lower number of days in the hospital. Less total 
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parenteral nutrition was needed in the experimental group in both 
settings, and the S-albumin level was significantly better preserved. No 
significant difference could be found with regard to infection rate. The 
study concluded oral cryotherapy reduced mucositis, number of hospital 
days, the need for total parenteral nutrition and resulted in a better 
nutritional status. 
Prescrire INT (2008) An experimental study was conducted to 
assess effectiveness orodental hygiene and the ice cubes in patients 
undergoing chemotherapy. Samples of 200 patients were randomized to 
suck ice chips during chemotherapy. The result showed that sucking ice 
during chemotherapy reduced the incidence of severe oral mucositis, 
from 14-74% to 4-21%. Analgesics especially morphine should be used 
to treat intense pain. Local anesthetics have not been tested in patients 
with damaged oral mucosa, but they can cause a burning sensation and 
carry a risk of swallowing disorders due to anesthesia of the 
oropharyngeal junction .The study concluded that In practice, prevention 
of oral mucositis due to cancer chemotherapy or radiotherapy is based 
on orodental care and ice rather than drugs. 
Papadeas E et al (2007) A prospective randomized study 
investigating whether oral cryotherapy alleviates chemotherapy induced 
oral mucositis. Thirty six patients, included in the cryotherapy group, 
were instructed to hold ice cubes in their oral cavity, shortly before, 
during and shortly after the infusion of chemotherapy. Both mean 
physician and patient-graded stomatitis of our cryotherapy group were 
compared with those of a control group (40 patients) and were found 
significantly reduced for all three chemotherapy cycles. The percentage 
of patients who were free from oral toxicity was significantly higher in 
the cryotherapy group in all three chemotherapy cycles, as judged both 
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by patients and physicians oral mucositis scale. The results of this study 
encourage the use of cryotherapy in patients receiving chemotherapy in 
alleviating oral mucositis by using a side-effect-free, easy to perform 
and inexpensive measure, which does not interfere with the efficacy of 
antineoplastic agents. 
Lilleby K et al (2006) A prospective, randomized study of 
cryotherapy during administration of chemotherapy. Forty patients with 
multiple myeloma scheduled to receive chemotherapy were randomly 
assigned to receive oral cryotherapy or room temperature normal saline 
rinses 30 min before and after the chemotherapy. Patients were 
evaluated for the development of mucositis using the National Cancer 
Institute grading system as well as evaluation of secondary measures 
such as days of total parenteral nutrition (TPN), narcotic use, 
hospitalization, weight loss and resumption of oral caloric intake. 
Patients self-scored their pain, swallowing, drinking, eating, sleeping 
and taste alterations. The primary end point of this trial was the 
incidence of grades 3-4 mucositis. Compared to the normal saline group, 
patients using cryotherapy experienced less grade 3-4 mucositis, 14 vs 
74%, P=0.0005. Patients receiving cryotherapy also had statistically 
lower uses of narcotics and TPN, although there were no differences in 
length of hospitalization or weight loss. Patient-reported pain was 
significantly lower and activities were significantly better in the 
cryotherapy group. 
Mustafa Baydar et al (2005) The study investigated the effects 
of local cryotherapy on oral mucositis incidence during administrated of 
chemotherapy. In a total of 99 courses, chemotherapy was given to 40 
patients. Findings from the study showed that while mucositis developed 
in 6.7% of the courses given with cryotherapy, this ratio was 38.9% in 
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courses given without cryotherapy. In the logistic regression analysis, 
development of mucositis had been found to correlate only with 
cryotherapy. Odds ratio (OR) = 11.5; in the 95% confidence interval 
(CI) = 3.2 - 41.9; (p = 0.001). The study concluded that the effects of 
cryotherapy in preventing oral mucositis due chemotherapy regimens 
were promising. 
Karagözoğlu S, Filiz Ulusoy M. (2005) The aim of the study was 
to investigate the effect of oral cryotherapy on the development of 
chemotherapy-induced mucositis in patients administered combined 
chemotherapy. Study involved 60 patients, 30 of whom were in the 
study group and 30 in the control group. Ice cubes at a size that can be 
moved easily in the mouth and whose corners have been smoothed in 
order that they will not cause irritation in the mouth has been used in 
oral cryotherapy in the study group. Oral chemotherapy was initiated 
five minutes before chemotherapy and maintained during venous 
infusions of etoposide (Vepesid), platinol (Cisplatin), mitomycin 
(Mitomycin-C) and vinblastin (Velbe) depending on the chemotherapy 
course. According to Patient-Judged Mucositis Grading, the rate of 
mucositis is 36.7% in study group and 90.0% in control group, the 
difference between two groups being statistically significant (P < 0.05). 
According to Physician-Judged Mucositis Grading, the rate of mucositis 
is 10.0% in the study group and 50.0% in the control group, the 
difference between two groups being statistically significant (P < 0.05). 
Oral pH values decreased in 90% of the subjects in study group, i.e. 
mucositis risk was reduced. The findings have demonstrated that oral 
cryotherapy makes an important contribution to the protection of oral 
health by reducing the mucositis score according to patient - and 
physician-judged mucositis score and by increasing oral pH values.  
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Nikoletti S et al (2005) The study aimed to compare the use of 
plain ice, flavoured ice and standard care, to evaluate the effect on 
mucositis and to determine patients' perceptions of the two forms of oral 
cryotherapy. Patients were randomized to receive each of three 
interventions across three cycles of chemotherapy: standard care alone; 
standard care plus plain ice; and standard care plus flavoured ice. Oral 
mucositis was assessed by nurses prior to each of the three 
chemotherapy cycles and 15 days after each intervention. Two 
assessment tools were used, the Oral Assessment Guide, and the 
Western Consortium Cancer Nursing Research Scale. Findings from 67 
patients revealed that when participants used standard care alone, they 
were significantly more likely to experience symptoms of mucositis than 
when they used either plain or flavoured ice.  
3. Studies related to pomegranet and its effect on cancer . 
Wang L et al. (2014) Prostate cancer is the second leading cause 
of cancer deaths in men in the United States. There is a major need for 
less toxic but yet effective therapies to treat prostate cancer. 
Pomegranate fruit from the tree Punica granatum has been used for 
centuries for medicinal purposes and is described as "nature's power 
fruit". Recent research has shown that pomegranate juice (PJ) and/or 
pomegranate extracts (PE) significantly inhibit the growth of prostate 
cancer cells in culture. In preclinical murine models, PJ and/or PE 
inhibit growth and angiogenesis of prostate tumors. More recently, we 
have shown that three components of PJ, luteolin, ellagic acid and 
punicic acid together, have similar inhibitory effects on prostate cancer 
growth, angiogenesis and metastasis. Results from clinical trials are also 
promising. PJ and/or PE significantly prolonged the prostate specific 
antigen (PSA) doubling time in patients with prostate cancer.  
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Viladomiu M et al (2013) Pomegranate fruit presents strong anti-
inflammatory, antioxidant, antiobesity, and antitumoral properties, thus 
leading to an increased popularity as a functional food and nutraceutical 
source since ancient times. It can be divided into three parts: seeds, peel, 
and juice, all of which seem to have medicinal benefits. Several studies 
investigate its bioactive components as a means to associate them with a 
specific beneficial effect and develop future products and therapeutic 
applications. Many beneficial effects are related to the presence of 
ellagic acid, ellagitannins (polyphenol formed from ellagic acid and 
anti-viral properties), punicic acid (anti-inflammatory), flavonoids 
(antioxidant), estrogenic flavonols (antioxidant and anti-inflammatory), 
and flavones which seem to be its most therapeutically beneficial 
components. However, the synergistic action of the pomegranate 
constituents appears to be superior when compared to individual 
constituents. Promising results have been obtained for the treatment of 
certain diseases including obesity, insulin resistance, intestinal 
inflammation, and cancer. To summarize there is a potential health 
effects and mechanisms of action of pomegranate extracts in 
inflammatory diseases. 
Ismail T, Sestili P, Akhtar S. (2012)  An extensive and 
systematic review of the extant literature was carried out, and the data 
under various sections were identified by using a computerized 
bibliographic search via PubMed, Web of Science and Google Scholar. 
All abstracts and full-text articles were examined. The most relevant 
articles were selected for screening and inclusion in this review. A 
variety of pomegranate ethnomedical uses have been recorded. 
Additionally, over the last decade, there has been a dramatic increase of 
interest in pomegranate as a medicinal and nutritional product due to its 
n1ewly identified potential health effects, which include treatment and 
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prevention of cancer and cardiovascular diseases. From the  toxicological 
perspective, pomegranate fruit juice, extracts and preparations have 
been proven to be safe. 
Rocha A, Wang L, Penichet M (2012)  Breast cancer is the most 
common cancer and the second leading cause of cancer death and 
morbidity among women in the western world. Pomegranate juice (PJ) 
and three of its specific components have been shown to inhibit 
processes involved in prostate cancer metastasis. If this also proves to 
be true for breast cancer, these natural treatments will be promising 
agents against breast cancer that can serve as potentially effective and 
nontoxic alternatives or adjuncts to the use of conventional selective 
estrogen receptor modulators for breast cancer prevention and treatment. 
To test this possibility, we have used two breast cancer cell lines, MDA-
MB-231 cells (ER(-)) and MCF7 (ER(+)), and the non-neoplastic cell 
line MCF10A. We show that, in addition to inhibiting growth of the 
breast cancer cells, PJ or a combination of its components luteolin (L) + 
ellagic acid (E) + punicic acid (P) increase cancer cell adhesion and 
decrease cancer cell migration but do not affect normal cells.  
Khan SA (2009) Colon cancer is one of the major causes of 
cancer-related death in the Western world. Although cytotoxic 
chemotherapeutic agents are available to treat the disease, these agents 
become ineffective as the disease advances to an invasive state. An 
alternative but viable approach to reduce the incidence of this deadly 
disease is then, to increase the dietary intake of relatively non-toxic 
fruits and vegetables. An example of a fruit with antioxidant, 
antidiabetic and anti-atherosclerotic properties is pomegranate. 
Pomegranate produces anticancer effects in experimental models of 
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lung, prostate and skin cancer. More recently, pomegranate has been 
found to be anti-carcinogenic in the colon. 
2.2 CONCEPTUAL FRAMEWORK 
Conceptual framework refers to framework of prepositions for 
conducting research. Conceptual framework serves as a spring board for 
theory development. As this made up of concepts which are mental 
images of a phenomenon. 
The conceptual framework setup for the study is Model of 
Widenbach‟s helping art of clinical nursing theory. Ernestine 
Wiedenbach proposed a prescriptive theory of nursing which is 
described as a conceiving of a desired situation and the ways to attain it. 
Prescriptive theory directs action towards an explicit goal. It consists of 
three factors: Central purpose, Prescription and realities. A nurse 
develops a prescription based on a central purpose and implements it 
according to the realities of the situation.  
 
THE MAIN CONCEPTS OF WIDENBACH’S HELPING ART 
OF CLINICAL NURSING THEORY ARE 
 Central purpose in the model refers to what the nurse wants 
to accomplish. It is the overall goal towards which a nurse 
strives: it transcends the immediate intent of the assignment 
or task by specifically directing activities towards the 
patients goal. 
 Prescription refers to the plan of care of the patient .It 
specifies the nature of the action that will fulfil the nurse‟s 
central purpose and the rationale for the action.  
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 Realities refer to physical, psychological, emotional and 
spiritual factors that come in to play in a situation involving 
nursing actions. The five realities identified by wiedenbach 
are agent, recipient, goal, means and framework, where the 
agent is the nurses desired outcome, the means are the 
activities and devices used by the nurse to achieve goal, and 
the frame work refers to the facilities in which nursing 
practiced. 
 Wiendenbach views nursing practice closely parallels the 
assessment, implementation and evaluation.  
STEPS OF THE NURSING PROCESS 
According to Wiedenbach nursing practice consists of 
 Identifying need for help 
 Ministering needed for help 
 Validating the need for help 
Investigator has selected this model for assessing the 
effectiveness of Pomegranate Popsicles on inflammation of the oral 
mucosa among first cycle chemotherapy patients at Dr.Kamakshi 
Memorial Hospital Chennai. This models views that Pomegranate 
Popsicles has preventive effect on inflammation of the oral mucosa 
among first cycle chemotherapy patients. The central purpose of  the 
study is to evaluate the effectiveness of Pomegranate Popsicles on 
inflammation of the oral mucosa among first cycle chemotherapy 
patients. 
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THE REALITIES IDENTIFIED IN THE STUDY ARE 
Agent – Investigator.  
Recipient - Chemotherapy patients who fulfill the inclusion criteria.  
Goal – Prevention of inflammation on the oral mucosa among 
chemotherapy patients  
Mean - Pomegranate Popsicles 
Environment – Chemotherapy Department of Dr.Kamakshi Memorial 
Hospital at Chennai. 
With the goal of improving the oral health among chemotherapy 
patients, the investigator as an agent conducted the study by ministering 
need for help through pomegranate popsicles application on oral mucosa 
there by preventing inflammation of oral mucosa. Chemotherapy 
patients are recipients of care. Dr.Kamakshi Memorial Hospital, 
Chennai is the selected environment. The pre-test level of the oral 
mucositis among chemotherapy patients were assessed using the WHO 
Oral Mucositis Scale. By validating the need for help the post test level 
of oral mucositis was assessed on seventh day after pomegranate 
popsicles application on oral mucosa. The effectiveness of the 
intervention (Pomegranate Popsicles) on oral mucosa has either positive 
outcome or negative outcome. The positive outcome reveals that 
pomegranate popsicles application effectively prevented the level of oral 
mucositis and hence the pomegranate popsicles application is effective. 
The negative outcome reveals that the intervention does  not prevent the 
oral mucositis occurrence. 
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FIGURE 1: CONCEPTUAL FRAME WORK BASED ON WIEDENBACH’S HELPING ART OF CLINICAL NURSING THEORY (1969)   
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CHAPTER – III 
RESEARCH METHODOLOGY  
This chapter deals with the description of different steps which 
are taken by the investigator for the present study. It comprises of the 
research approach, research design, variables, research setting, 
population, sample and sample size, sampling technique, sampling 
criteria, development and description of tool, Validity and reliability of 
the tool, ethical considerations, pilot study, data collection procedure, 
and plan for statistical data analysis.  
3.1 RESEARCH APPROACH 
Research approach is an umbrella that covers the basic procedure 
for conducting research. The research approach adopted in this study is 
Quantitative Research approach in nature focusing on the effectiveness 
of Pomegranate Popsicles on Inflammation of the oral mucosa among 
chemotherapy patients. 
3.2 RESEARCH DESIGN 
The research design adopted for the present study is Quasi 
experimental post test only control group research design.  
Group Pre-Test Intervention Post-Test 
Experimental Group   -  X O2  
Control Group -   -  O2  
 Key: 
O1 – Pre test 
          X – Pomegranet Popsicles  
         O2 –  Post test 
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3.3 VARIABLES OF THE STUDY 
Independent variable:  Pomegranate Popsicles 
Dependent variable:  Inflammation of the oral mucosa 
3.4 SETTING OF THE STUDY 
Dr.Kamakshi Memorial Hospital a Super speciality hospital 
providing services to all the divisions of health care including cancer 
care, pioneered not only in advanced scientific management of diseases 
but also in equipping with modern technologically advanced Gadgets.  
       This hospital provides services to all the divisions of health care 
including advanced care with Chemotherapy, Brachytherapy & 
Radiotherapy for cancer patients. This well-established 150-bed 
multispecialty hospital caters to millions of people in and around the 
Chennai metropolitan area. The hospital also serves a number of patients 
from abroad. Their success rates are comparable to the best centers in 
the world. Committed to deliver scientific modern medical care to the 
society with International standards at an affordable cost, this hospital 
treats more than 2000 cancer patients per year.  
3.5 POPULATION 
The population of the study includes patients on chemotherapy in 
Dr. Kamakshi Memorial Hospital. 
3.6 SAMPLES 
The samples were 60 cancer patients on chemotherapy who fulfill 
inclusion criteria. 
3.7 SAMPLE SIZE 
 Sample size is 60.  (Experimental group 30, Control Group 30) 
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3.8 SAMPLE SELECTION CRITERIA 
INCLUSION CRITERIA 
Study includes: - Patients who are; 
1. On the first cycle of chemotherapy.  
2. Willing to participate at the time of the study.  
3. Between 30 years to 60 years of age.  
EXCLUSION CRITERIA 
1. Patients who underwent oral surgery.  
2. Patients who have oral Mucositis prior to chemotherapy.  
3. Patients who have oral cancer.  
3.9 SAMPLING TECHNIQUE 
The subjects of the present study were selected by non 
probability, purposive sampling technique. 
3.10 DEVELOPMENT OF THE TOOL  
The tools were standardized – W.H.O - ORAL MUCOSITIS SCALE 
3.11 DESCRIPTION OF THE TOOL 
The tool consists of two parts: Part I and Part II  
Part I: 
Demographic variable of the patients receiving chemotherapy such as 
age, sex, religion, education, occupation, food habits, oral hygiene. 
Part II: W.H.O. Oral Mucositis Assessment Scale. 
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3.12 ETHICAL CONSIDERATION 
The proposed study was conducted after the approval of the ethics 
committee of Venkateswara Nursing College, Thalambur, Chennai. 
Permission was obtained from Dr. Kamakshi Memorial Hospital, 
assurance was given to the patients that confidentiality of each patient 
will be maintained and written consent was obtained.  The participants 
were informed that they are free to withdraw from the study at any time 
during the course of the study period if they wish. 
3.13 TESTING OF THE TOOLS 
The content validity of the tool was established on the basis of 
opinion from five experts. 
3.13.1 CONTENT VALIDITY 
In order to determine the content validity, the tool was submitted 
to Nursing Experts in the specialty of Medical Surgical Nursing, a 
Medical Expert who is a Surgical Oncologist and a Statistician who is a 
Research Officer and their suggestions were incorporated in the tool. 
There was no ambiguity in language in the tool and the tool was found 
feasible. 
3.13.2 RELIABILITY OF THE TOOL 
In order to determine the Reliability of the tool test retest method 
was used and the tool was found to be reliable.  The reliability of the tool 
was by test retest method found (r=0.8), and the tool was considered as 
fit for proceeding with pilot study. 
3.13.3 PILOT STUDY 
A pilot study was conducted to assess the feasibility and 
practicability of the tool and it also helped to determine the plan of data 
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analysis. Prior permission to conduct the study was obtained from the 
administration of Dr.Kamakshi Memorial Hospital on 6.9.14 to11.9.14 
who fulfill the inclusion criteria were selected (experimental group-3, 
control group-3) by non probability purposive sampling technique. The 
purpose of the study was explained to subjects and a written consent was 
obtained from them. Confidentiality was assured to all the subjects. The 
demographic data was collected with the help of questionnaire. The tool 
used is a standardized WHO oral mucositis Scale. Data collected was 
analyzed using descriptive and inferential statistics. The results showed 
that there was significant difference among the post test levels of oral 
mucositis in experimental and control group, the tool was found feasible 
to proceed for the main study. 
3.14 DATA COLLECTION PROCEDURE 
The main study was conducted in Dr.Kamakshi Memorial 
Hospital Pvt.Ltd., Radial Road, Pallikaranai, Chennai,  after obtaining 
permission from the concerned hospital authority. Purposive sampling 
technique was used to select 30 samples into experimental group and 30 
patients into control group based on inclusion criteria. The study lasted 
for a period of 4 weeks during which, the first and second weeks 
subjects were taken as experimental group and in the third and fourth 
weeks subjects were taken as control group.  
Phase -1 Demographic data was collected from the subjects using a 
questionnaire. 
Phase-2: Intervention with pomegranate popsicles was given to subjects 
in the experimental group on the same day. Pomegranate Popsicles was 
given to patients 5 minutes prior to, maintained 5 minutes  during 
infusion and 5 minutes after infusion of chemotherapeutic agent.  The 
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subjects were asked to keep the popsicles inside the mouth in contact 
with the inner cheek wall of the oral cavity, the right side first and then 
on the left side, thereby cooling the oral cavity. The subjects in the 
control group followed the routine standard care of mouth wash with 
fresh water three times a day.  
Phase-3 Post test level or oral mucositis was assessed on the seventh 
day using the W.H.O Oral Mucositis Scale. The data was then organized 
for statistical analysis. 
3.15 DATA ANALYSIS PROCEDURE 
Data collected analysed by using descriptive and inferential 
statistics on the basis of objectives and inferential statistics on the basis 
of the objectives and hypotheses of the study. 
DESCRIPTIVE STATISTICS 
 Frequency, percentage distribution, will be used to describe 
demographic variables. 
 Mean and standard deviation will be used to assess the level of 
oral mucositis in patient undergoing chemotherapy. 
INFERENTIAL STATISTICS 
 Paired t test will be used to compare the post-tests mean score 
level of inflammation of the oral mucosa among patients on 
chemotherapy in experimental and control group. 
 Chi- square test will be used to find the association between the 
post-tests mean score level of inflammation of the oral mucosa 
among patients on chemotherapy and their selected demographic 
variables. 
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FIGURE 2: SCHEMATIC REPRESENTATION OF STUDY DESIGN  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Population 
Patients undergoing First Cycle Chemotherapy 
Sample 
First Cycle Chemotherapy who fulfill the criteria  
Sampling Technique 
Non Probability purposive sampling 
Sample Size : 60 
  Experimental Group: 30        Control Group: 30 
Pomegranate Popsicles Standard Hospital Care 
Assessment of post test level of oral mucositis by W.H.O Oral 
Mucositis Scale on seventh day 
Data Analysis 
Descriptive and Inferential Statistics 
Study Findings and Conclusion 
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CHAPTER – IV 
DATA   ANALYSIS AND INTERPRETATION 
Processing the data implies coding, classification and tabulation 
of collected data that they are amenable to analysis.  
Analysis is defined as categorizing, ordering, manipulating, and 
summarizing of data to reduce to intelligible and interpretable form, so 
that research problems can be studied and tested with relationship 
between the variables – (Polit and Hungler, 2008). 
The chapter deals with the analysis and interpretation of data. 
Data collected from 60 patients on first cycle chemotherapy were 
analyzed to assess the effectiveness of Pomegranate Popsicles on 
inflammation of the oral mucosa among chemotherapy Patients and 
tabulated according to the plan for data analysis and are interpreted 
according to the following headings: 
ORGANIZATION OF DATA 
The data obtained from samples of 60 patients were analysed and 
presented in this chapter under the following headings:  
Section-I Distribution of subjects according to their selected 
demographic variables. 
Section-II   Comparison of the post-test level of oral mucositis among 
experimental and control group. 
Section-III   Effectiveness of pomegranet popsicles  on the level of oral 
mucositis among experimental and control group. 
Section-IV   Association in the level oral mucositis among 
experimental and control group with the selected 
demographic variables. 
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SECTION I-A: DISTRIBUTION OF SUBJECTS ACCORDING 
TO THEIR SELECTED DEMOGRAPHIC VARIABLES. 
Table – 4.1: Frequency and Percentage Distribution of Subjects 
According to Demographic Variables                                                                                                                                                                    
N = 60 
S.No 
Demographic 
variables 
Experimental Group 
(n=30) 
Control Group 
(n=30) 
f % f % 
1. Age ( in years)  
a) 30-39 
b) 40-49 
c) 50-60 
 
3 
7 
20 
 
10.0 
23.3 
66.7 
 
4 
7 
19 
 
13.3 
23.3 
63.3 
2. Sex 
a)  Male 
b)  Female 
      9 
21 
30.0 
70.0 
8 
22 
26.7 
73.3 
3. Marital Status 
a) Married 
b) Unmarried 
c) Widower 
d) Divorced 
      
      26 
- 
4 
- 
 
86.7 
- 
13.3 
       - 
 
26 
- 
4 
- 
 
86.7 
- 
13.3 
- 
4. Religion 
a) Hindu 
b) Muslim 
c) Christian 
d) Others 
 
25 
2 
3 
- 
 
83.3 
6.7 
10.0 
- 
 
28 
1 
1 
- 
 
93.3 
3.3 
3.3 
- 
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5. Educational Status 
a) Un Educated 
b) Primary School  
c) High School  
d) Graduate 
 
- 
3 
11 
16 
 
- 
10.0 
36.7 
53.3 
 
- 
2 
14 
14 
 
- 
6.7 
46.7 
46.7 
6. Occupation 
a) Home Maker 
b) Government  
c) Private 
d) Business 
 
18 
- 
9 
3 
 
60.0 
- 
30.0 
10.0 
 
22 
- 
4 
4 
 
73.3 
- 
13.3 
13.3 
7. Type of Activity  
a) Sedentary 
b) Moderate 
c) Heavy 
 
7 
22 
1 
 
23.3 
73.3 
3.3 
 
2 
28 
- 
 
6.7 
93.3 
- 
8. Monthly Income  
a) <  Rs.8000/- 
b) Rs.8001–10000/- 
c) Rs.10001–15000/- 
d) > Rs.15001/- 
 
- 
- 
- 
30 
 
- 
- 
- 
100 
 
- 
- 
- 
30 
 
- 
- 
- 
100 
9. Family History of  
Cancer 
a) Yes 
b) No 
 
      7 
23 
 
23.3 
76.7 
 
4 
26 
 
13.3 
86.7 
10. Family History of 
Chemotherapy 
a) Yes 
b) No 
 
5 
25 
 
16.7 
83.3 
 
4 
26 
 
13.3 
86.7 
  38 
This table describes the frequency and percentage distribution of 
samples according to demographic variables.  
In regard to age, out of 60 samples, 3 (10%) of them were found 
to be the age group between 30 and 39 years, the age of 7 ( 23.3%) in 
the age group between 40 and 49 years, 20 (66.6%) in the age group 
between 50 and 60 years. Considering the control group, the age of 
patients undergoing chemotherapy 4 (13.3%) of them were found to be 
the age group between 30 and 39 years, the age of 7 (23.3%) in the  age 
group between 40 and 49 Years, 19 (63.3% )in the age group between 50 
and 60 years. 
Regarding sex; 9 (30 %) are male patients and 21 (70 %) are 
female patients in experimental group; in control group 8 (26.7%) of 
them were male and 22 (73.3%) of them were females. Regarding 
marital status, 26 (86.7%) are married; 4 (13.3%) are widow; 
considering the control group 26 (86.7%) are married; 4 (13.3%) are 
widow. 
Considering Religion; in experimental group 25 (83.3%) are 
Hindu; 2 (6.7%) are Muslim; 3 (10%) are Christian; in control group, 28 
(93.3%) are Hindu; 1 (3.3%) is Muslim; 1 (3.3%) is Christian . 
Considering Educational status, in experimental group 3 (10%) are 
Primary School; 11 (36.7%) are High School; 16 (53.3%) are Graduate; 
In control group 2 (6.7%) are Primary School; 14 (46.7%) are High 
School; 14 (46.7 %) are Graduate. 
With respect to occupation; in experimental group, 18 (60%) 
patients are Home Makers; 9 (30%) patients are Private sector workers; 
3 (10%) patients are doing Business; In control group 22 (73.3%) 
patients are Home Makers; 4 (13.3%) patients are Private sector workers 
and 4 (13.3%) patients are doing Business. 
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Regarding the type of activity; in experimental group, 7 (23.3%) 
patients are Sedentary Workers; 22 (73.3%) patients are Moderate 
Workers; 1 (3.3%) patient is a Heavy Workers; in control group 2 
(6.7%) patients are Sedentary Workers and 28 (93.3%) patients are 
Moderate Workers. Considering the Monthly Family income in 
experimental group and control group all patients have a family monthly 
income above >15000/-.  
Considering the Family History of Cancer; in experimental group 
7 (23.3%) of patients have a family history of cancer and 23 (76.7%) do 
not have a family history of cancer; considering the control group 4 
(13.3%) have family history of cancer and 26 (86.7%) do not have a 
family history of cancer. Considering the Family History of 
Chemotherapy; in experimental group, 5 (16.7%) patients have a 
relative undergoing chemotherapy; 25 (83.3%) patients do not have 
relatives undergoing chemotherapy. In control group 4 (13.3%) patient 
has a relative undergoing chemotherapy and 26 (86.7%) patients do not 
have relatives undergoing chemotherapy. 
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SECTION I-B: ASSESSMENT OF DEMOGRAPHIC 
VARIABLES OF PATIENTS UNDERGOING 
CHEMOTHERAPY IN EXPERIMENTAL AND CONTROL 
GROUP WITH RESPECT TO ORAL HYGIENE 
Table – 4.2: Frequency and percentage distribution of demographic 
variables in experimental and control group with respect to oral 
hygiene                                                                                        N=60 
S.No 
Demographic variables 
Experimental 
Group 
(n=30) 
Control 
Group 
(n=30) 
f % f % 
1 Mouth Wash 
a) Yes 
b) No 
 
6 
24 
 
20.0 
80.0 
 
3 
27 
 
10.0 
90.0 
2 Frequency of Brushing per 
day 
a) None 
b) Once 
c) Twice 
d) Thrice 
 
 
- 
4 
26 
- 
 
 
- 
13.3 
86.7 
- 
 
 
- 
7 
23 
- 
 
 
- 
23.3 
76.7 
- 
3 Item used for brushing 
a) Tooth Powder 
b) Toothpaste 
c) Charcoal Powder 
d) Chewing Stick 
 
     - 
29 
1 
- 
 
- 
96.7 
3.3 
- 
 
- 
27 
3 
- 
 
- 
90.0 
10.0 
- 
4 Frequency of Gargle per 
day 
a) None 
b) Once 
c) Twice 
d) Thrice 
 
 
9 
4 
16 
1 
 
 
30.0 
13.3 
53.3 
3.3 
 
 
13 
8 
8 
1 
 
 
43.3 
26.7 
26.7 
3.3 
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Table 4.2 shows concerning Oral Hygiene, 5 (16.6%) patients in the 
experimental group use mouth wash solution; 25 (83.3%) patients do not 
use mouth wash solution. In control group 2 (6.6%) patients use mouth 
wash solution and 28 (93.3%) patients do not use mouth wash solution.  
Regarding brushing habits, 4 (13.3%) patients in the experimental group 
brush once a day; 26 (86.6%) patients brush twice a day.  
In control group 7 (23.3%) patients brush once a day and 23 (76.6%) 
brush twice a day. 
In experimental group 29 (96.6%) patients use toothpaste; 1 (3.3%) 
patient uses charcoal powder and in control group 30 (100%) patients 
use only toothpaste. 
In experimental group 9 (30%) patients do not have the habit of 
gargling, 4 (13.3%) gargle once a day, 16 (53.3%) gargle twice a day 
and 1 (3.3%) patient gargles thrice a day. In control group 13 (43.3%) 
patients do not gargle, 8 (26.6%) gargle once a day, 8 (26.6%) gargle 
twice a day and 1 (3.3%) patient gargles thrice a day. 
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FIGURE 3: PERCENTAGE DISTRIBUTION OF SAMPLES ACCORDING TO ITEM USED FOR BRUSHING 
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FIGURE 4: PERCENTAGE DISTRIBUTION ACCORDING TO FREQUENCY OF GARGLE PER DAY
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SECTION I-C: ASSESSMENT OF DEMOGRAPHIC 
VARIABLES OF PATIENTS UNDERGOING 
CHEMOTHERAPY IN EXPERIMENTAL AND CONTROL 
GROUP WITH RESPECT TO DIET 
Table 4.3: Frequency and percentage distribution of demographic 
variables of patients undergoing chemotherapy in 
experimental and control group with respect to diet. 
                                                                                (N=60) 
Demographic variables 
Experimental Group 
(n=30) 
Control Group 
(n=30) 
f % f % 
Dietary Pattern 
a) Vegetarian 
b) Non Vegetarian 
 
9 
21 
 
30.0% 
70.0% 
 
6 
24 
 
20.0% 
80.0% 
Eating Sweets 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
8 
- 
14 
8 
 
26.7% 
- 
46.7% 
26.7% 
 
6 
- 
10 
14 
 
20.0% 
- 
33.3% 
46.7% 
Chat items in diet 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
7 
- 
15 
8 
 
23.3% 
- 
50.0% 
26.7% 
 
1 
1 
26 
2 
 
3.3% 
3.3% 
86.7% 
6.7% 
Fizzy Drinks 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
22 
- 
5 
3 
 
73.3% 
- 
16.7% 
10.0% 
 
20 
- 
4 
6 
 
66.7% 
- 
13.3% 
20.0% 
  45 
 
This table 4.3 presents regarding Dietary Pattern in experimental 
group 9 (30%) patients are vegetarian and 21 (70%) are Non 
Vegetarian. In control group 6 (20%) patients are vegetarian and 
24 (80%) are Non Vegetarian. 
In experimental group 8 (26.6%) patients never eat sweets; 14 
(46.6%) patients eat sweets few times a week; 8 (26.6%) eat 
sweets only few times a month. In the control group 6 (20%) 
patients never eat sweets; 10 (33.3%) eat sweets few times a week 
and 14 (46.6%) eat sweets only few times a month.  
In experimental group 7 (23.3%) patients never eat chat items; 15 
(50%) patients eat chat items few times a week; 8 (26.6%) eat 
chat items only few times a month. In the control group 1 (3.3%) 
patient never eats chat items; 26 (86.6%) eat chat items few times 
a week and 2 (6.6%) eat chat items only few times a month.  
In experimental group 22 (73.3%) patients never drink fizzy 
drinks; 5 (16.6%) patients drink fizzy drinks few times a week; 3 
(10%) eat drink fizzy drinks only few times a month. In the 
control group 20 (66.6%) patient never drink fizzy drinks; 4 
(13.3%) drink fizzy drinks few times a week and 6 (20%) drink 
fizzy drinks only few times a month. 
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FIGURE 5: PERCENTAGE DISTRIBUTION OF SAMPLES ACCORDING FREQUENCY OF TAKING CHATS
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SECTION I-D: ASSESSMENT OF DEMOGRAPHIC 
VARIABLES OF PATIENTS UNDERGOING 
CHEMOTHERAPY IN EXPERIMENTAL AND CONTROL 
GROUP WITH RESPECT TO HABITS 
Table – 4.4: Frequency and Percentage Distribution of Samples 
According to Demographic Variables                                                                                                                                                                    
N = 60 
Demographic variables 
Experimental Group 
(n=30) 
Control Group 
(n=30) 
f % f % 
Chewing Tobacco 
a) Yes 
b) No 
 
5 
25 
 
16.7 
83.3 
 
9 
21 
 
30.0 
70.0 
Smoking or Drinking Alcohol 
a) Yes 
b) No 
 
2 
28 
 
6.7 
93.3 
 
5 
25 
 
16.7 
83.3 
This table 4.4 shows regarding Habits; in experimental group 4 (13.3%) 
patients have the habit of chewing tobacco; whereas 26 (86.6%) patients 
do not chew tobacco. In control group, 3 (10%) patients chew tobacco 
and 27 (90%) patients do not chew tobacco. 
In experimental group 2 (6.6%) patients have the habit of smoking or 
drinking and 28 (93.3%) do not have the habit of smoking or drinking 
alcohol. In control group also 2 (6.6%) patients have the habit of 
smoking or drinking and 28 (93.3%) do not have the habit of smoking or 
drinking alcohol. 
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SECTION-II: COMPARISON OF POST-TEST LEVEL OF ORAL 
MUCOSITIS AMONG EXPERIMENTAL AND CONTROL GROUP. 
Table –4.5 Frequency and percentage distribution of post test level of 
oral mucositis among chemotherapy patients in in experimental and 
control group. 
                                                                                 N=60 
Level of Oral Mucositis 
Experimental group Control group 
f % f % 
None  (0) 23 77 17 57 
Mild  (1) 7 23 7 23 
       Moderate  (2) 0 0 6 20 
            Severe  (3) 0 0 0 0 
Intravenous Feeding  (4) 0 0 0 0 
Total 30 100 30 100 
The above table-4.5 depicts that in the experimental group 23 
(77%) of them did not develop oral mucositis, 7 (23%) of them had mild 
level of oral mucosits and none of them had moderate,  severe or 
intravenous feeding level of oral mucositis. In control group none of the 
patients had sever or intravenous feeding level of oral musocitis,  6 
(20%) of them had moderate level of oral mucositis , 7 (23%) of them 
had mild oral mucosits and 17 (57%) of patients did not develop oral 
mcositis.  
Furthermore in experimental group, only 23% of patients 
developed oral mucositis, whereas in control group 43% of patients 
developed oral mucositis.  
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FIGURE 6: FREQUENCY OF LEVEL OF ORAL MUCOSITIS AMONG CHEMOTHERAPY PATIENTS
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Control Group
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SECTION-III: EFFECTIVENESS OF POMEGRANET 
POPSICLES ON THE LEVEL OF ORAL MUCOSITIS 
AMONG EXPERIMENTAL AND CONTROL GROUP 
Table 4.6 Paired ‘t’ test value of the oral mucositis score of 
chemotherapy patients among experimental and control group 
         N=60 
S.No Variable 
Experimental 
Group 
(n=30) 
Control Group 
(n=30) 
df t   p value 
Mean SD Mean SD 
1. 
Pomegranate 
Popsicles 
0.23 0.430 0.63 0.809 58 2.392 
 
0.02* 
 
* The result is significant at p < 0.05. 
 
  The above table 4.6 shows the effectiveness of pomegranate popsicles 
on inflammation of the oral mucosa among chemotherapy patients. The 
paired „t‟ test gave a „t‟ value of 2.392, at df  =58, the p value was 0.02 
which is significant at p < 0.05 level.  
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SECTION-IV: ASSOCIATION OF LEVEL ORAL MUCOSITIS 
AMONG EXPERIMENTAL AND CONTROL GROUP WITH THE 
SELECTED DEMOGRAPHIC VARIABLES. 
 
Table 4.6 Association of post test levels of oral mucositis among 
experimental and control group with the selected demographic variables 
 N=60 
S.No 
Demographic 
variables 
Level of Oral 
Mucositis 
Chi-
Square 
p 
value 
None Mild Moderate 
1. 
Age ( in years)  
a) 30-39 
b) 40-49 
c) 50-60 
 
7 
11 
22 
 
- 
2 
12 
 
- 
1 
5 
0.168 
0.919 
NS 
2. 
Sex 
 a)Male 
 b)Female 
 
8 
32 
 
6 
8 
 
3 
3 
0.082 
0.774 
NS 
3. 
Educational Status 
a) Un Educated 
b) Primary School  
c) High School  
d) Graduate 
 
- 
3 
15 
22 
 
- 
- 
7 
7 
 
        - 
2 
3 
1 
0.693 
0.707 
NS 
4. 
Occupation 
a) Home Maker 
b) Government  
c) Private 
d) Business 
 
28 
- 
9 
3 
 
9 
- 
4 
1 
         
         - 
- 
3 
3 
2.466 
0.291 
NS 
5. 
Type of Activity  
a) Sedentary 
b) Moderate 
c) Heavy 
 
8 
31 
1 
 
- 
14 
- 
 
        1 
5 
- 
4.498 
0.106 
NS 
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6. 
Family H/o Cancer 
a) Yes 
b) No 
 
4 
36 
 
5 
9 
 
2 
4 
1.002 
0.317 
NS 
7. 
Mouth Wash 
a) Yes 
b) No 
 
5 
35 
 
2 
12 
 
1 
5 
1.176 
0.278 
NS 
8. 
Frequency of 
Brushing per day 
a) None 
b) Once 
c) Twice 
d) Thrice 
 
 
- 
7 
33 
- 
 
 
- 
2 
12 
- 
 
 
- 
2 
4 
- 
1.002 
0.317 
 NS 
9. 
Item used for 
brushing 
a) Tooth Powder 
b) Toothpaste 
c) Charcoal Powder 
d) Chewing Stick 
 
- 
40 
- 
- 
 
- 
13 
1 
- 
 
       - 
3 
3 
- 
4.13 
 
0.041*  
 
10. 
Frequency of Gargle 
per day 
a) None 
b) Once 
c) Twice 
d) Thrice 
 
 
14 
5 
19 
2 
       
 
5 
5 
4 
- 
 
       
       3 
2 
1 
- 
4.727 
0.193 
NS 
 
Dietary Pattern 
a) Vegetarian 
b) Non Vegetarian 
 
9 
31 
 
4 
10 
 
2 
4 
0.800 
0.371 
NS 
 
Eating Sweets 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
7 
- 
16 
27 
 
5 
- 
6 
3 
 
2 
- 
2 
2 
2.589 
0.274 
NS 
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* Significant at 0.05 level            NS – Not Significant 
 
  
      This table shows the association between the level of oral mucositis 
and selected demographic variables of patients with cancer who are 
undergoing chemotherapy. The results showed that there was no 
significant association of the post-test level of oral mucositis and 
demographic variables such as Age, Sex, Education, occupation, type of 
activity, Family History of cancer, Use of Mouth wash, frequency of 
brushing, Item used for brushing,  Frequency of gargle, Diet pattern, 
tobacco chewing, smoking and drinking. The results shows  an 
association of item used for brushing and chat items with inflammation 
of oral mucosa, statically significant at p<0.05 level 
 
 
Chat items in diet 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
5 
1 
28 
6 
 
3 
- 
7 
4 
 
- 
- 
6 
- 
12.051 .007* 
 
Fizzy Drinks 
a) Never 
b) Everyday 
c) Few times a week 
d) Few times a month 
 
26 
- 
8 
6 
 
12 
- 
- 
2 
 
4 
- 
1 
1 
1.206 
0.547 
NS 
 
Chewing Tobacco 
a) Yes 
b) No 
 
1 
39 
 
8 
6 
 
5 
1 
1.491 
0.222 
NS 
 
Smoking or Drinking 
Alcohol 
a) Yes 
b) No 
 
 
- 
40 
 
 
3 
11 
 
 
4 
2 
 
1.456 
 
0.228 
NS 
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CHAPTER-V 
DISCUSSION 
This chapter discusses the major findings of the study and reviews them 
in relation to finding from other studies.  
The aim of the study was to assess the Effectiveness of Pomegranate 
Popsicles on Inflammation of the oral mucosa among Patients on 
Chemotherapy in a Selected Hospital at Chennai.  
In this study Quasi experimental, post test only control group design was 
adopted. Sixty sample were selected by purposive sampling, and the 
samples were assesses and those fulfilling the inclusion criteria were 
selected in experimental and control groups. Demographic data was 
collected by using a questionnaire. Intervention with pomegranate 
popsicles was given to the patient in the experimental group, the control 
group followed the standard hospital care with fresh water mouth wash. 
Post test was conducted on the seventh day to assess the level of oral 
mucositis using a W.H.O Oral Mucositis Scale.  The data was organized 
and analyzed and the major results of the study are discussed according 
to the objectives. 
MAJOR FINDINGS OF THE STUDY AND DISCUSSION 
Majority of the samples were in the age group of 50 – 60 years (65%). 
Females were more affected by cancer than males (71.7%). 86.7% of 
patients were married where as 13.3% of them were widows. Most of 
the samples were Hindus (88.3%). About 50% of the samples were 
graduates. About 66.7% of patients were home makers. 83.3% of 
patients were sedentary workers.  
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All the patients had a monthly family income of more than Rs.15, 000. 
per month. 18.3% of patients had relatives diagnosed with cancer.  
And 15% of patients had relatives who underwent chemotherapy. 
Regarding oral hygiene, 15% of patients used oral mouth wash. 
Majority of the patients, 81.7% had the habit of brushing twice 
daily. About 6.7% of patients used charcoal for brushing the teeth. 
About 40% of the patients had the habit of gargle thrice a day. 
Considering Dietary Pattern, 75% of the patients were non 
vegetarians. 40% of patients had the habit of eating sweets few 
times a week.  68.3% of patients used chat items in their diet few 
times a week. Majority of patients to 70% never take fizzy drinks. 
Considering habits, 23.3% of patiemt chew tobacco.  11.7 % of 
patients had the habit of drinking and smoking.  
The results were supported by a study conducted by J. M. de 
Rijke et.al on Age-specific differences in the diagnostics and 
treatment of cancer patients in the province of Limburg, the 
Netherlands. The diagnosis was confirmed that in 88% of the total 
patient population. 93% of cancer patients were of age category 
50-59 years, 90% in 60-69 years and 83% in70.The study 
projection shows that majority or cancer patients were in 50-59 
years of age group. 
The findings of the study based on the objectives:  
To evaluate the effectiveness of pomegranate popsicles on oral 
mucositis among patients receiving chemotherapy in 
experimental and control group. 
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Comparison of Frequency and Percentage Distribution 
The analysis showed 77% of patients in experimental group 
of them did not develop oral mucositis, 23% of them had mild 
level of oral mucosits and none of them had moderate,  severe or 
intravenous feeding level of oral mucositis. In control group none 
of the patients had sever or intravenous feeding level of oral 
musocitis, 20% of them had moderate level of oral mucositis,  23% 
of them had mild oral mucosits and 57% of patients did not 
develop oral mcositis.  
Furthermore, in experimental group only 23% of patients 
developed oral mucositis, whereas in control group 43% of 
patients developed oral mucositis. Thus patients were 20% less 
likely to develop oral mucositis when given pomegranate 
popsicles during chemotherapy. 
This result was supported by Cascinu S et.al randomized study 
demonstrating the utility of oral cooling (cryotherapy) in the 
prevention of chemotherapy induced oral mucositis.  Mucositis 
was significantly reduced by cryotherapy considering both the 
first cycle of therapy (the mean toxicity score for cryotherapy was 
0.59 and it was 1.1 for the control group, P < or = 0.05) and all 
the chemotherapeutic courses (the mean toxicity score for 
cryotherapy was 0.36 when it was 0.69 for the control group, P < 
or = 0.05).  
In conclusion, the present study confirms that cryotherapy can 
prevent and decrease chemotherapy induced oral mucositis and 
should be recommended for patients receiving chemotherapy 
regimens. 
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Mean, Standard Deviation and Paired ‘t’ test value 
The study findings revealed that the paired „t‟ test gave a „t‟ value 
of 2.392, at df=58, the p value was 0.02  which is significant at     
p < 0.05 level. Hence the research hypothesis (H1) was accepted.             
 
        This result is supported by  Karagözoğlu S et.al (2005) study 
investigating the effect of oral cryotherapy on the development of  
chemotherapy-induced mucositis. According to Patient-Judged 
Mucositis Grading, the rate of mucositis is 36.7% in study group 
and 90.0% in control group, the difference between two groups 
being statistically significant (P < 0.05). According to Physician-
Judged Mucositis Grading, the rate of mucositis is 10.0% in the 
study group and 50.0% in the control group, the difference 
between two groups being statistically significant (P < 0.05). 
Hence pomegranate popsicles have a significant effect on 
preventing and reducing inflammation of the oral mucosa among 
chemotherapy patients. 
The second objective of the study was to out find out the 
association between the post-test levels of oral mucositis among 
patients receiving chemotherapy with their selected demographic 
variables. 
The results showed that there was no significant association of the 
post test level of oral mucositis and demographic variables such 
as Age, Sex, Education, occupation, type of activity, Family 
History of cancer, Use of Mouth wash, frequency of brushing, 
Item used for brushing,  Frequency of gargle, Diet pattern, 
tobacco chewing, smoking and drinking. The results revealed  an 
association of item used for brushing and chat items in diet with 
inflammation of oral mucosa, at p<0.05 level  
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                Hence there is an association with respect to selected 
demographic variables. Hence the corresponding research 
hypothesis H2: Stated earlier “There is a significant association 
between the post-test levels of inflammation of the oral mucosa 
among patients on chemotherapy with their selected demographic 
variables.” was retained. 
     This result is supported by Dorothy M. Keefe et al (2008)  
study conducted on Updated clinical practice guidelines for the 
prevention and treatment of mucositis. The results from this study 
showed that what the patient used for brushing had a significant 
reduction in level of oral mucositis. When analyzed the 
association of demographic variables what is used for brushing 
showed a statistical significance in level of oral mucositis 
comparing before and after the intervention.  
. 
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CHAPTER – VI 
SUMMARY, CONCLUSION, IMPLICATIONS, 
RECOMMENDATIONS AND LIMITATIONS 
This chapter summarizes the findings, understanding and 
interpretation of results and recommendations that incorporate the 
implications such as nursing practice, nursing education, nursing 
administration, and nursing research. It also gives meaning to the results 
obtained in the study. 
6.1 SUMMARY 
A person diagnosed with cancer may undergo surgery, radiation or 
chemotherapy as a management of cancer, among which chemotherapy 
is the commonest treatment modality. Many oral complications arise as 
a side effect of chemotherapy, among these oral mucositis is a major 
nonhematologic complication of cytotoxic chemotherapy.  Preventing a 
complication beforehand is much easier and less costly than treating it. 
In this context, cryotherapy (oral cooling using ice) has become a cheap 
and readily applicable method in preventing or decreasing oral mucositis 
developing due to chemotherapy. As ice cubes can be made readily 
available and cheaper, people undergoing chemotherapy may effectively 
use this in their due course of therapy. With enough scientific evidence 
supporting cryotherapy as the best treatment to prevent oral mucositis 
and recommendation for further research with frozen fruit juices, the  
investigator had an intense curiosity to assess the effectiveness 
pomegranate popsicles over oral mucositis among the patients receiving 
chemotherapy thereby undertaking this study.  
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The objectives of the study, 
 To evaluate the effectiveness of pomegranate popsicles on oral 
mucositis among patients receiving chemotherapy in experimental 
and control group. 
 To find out the association between the post-test level of oral 
mucositis among patients receiving chemotherapy with their 
selected demographic variables. 
The research hypothesis,  
H1 – There is a significant difference in the post-tests level in 
inflammation of the oral mucosa among patients on chemotherapy 
between experimental and control group.  
H2 - There is a significant association between the post -test levels of 
inflammation of the oral mucosa among patients on chemotherapy 
with their selected demographic variables. 
Review of literature was done related to: 
1) Studies related to oral mucositis as a side effect of cancer  
2) Studies related to the prevention of oral mucositis by cryotherapy 
3) Studies related to pomegranate and its effect on cancer   
The conceptual framework opted for this study was Widenbach‟s 
helping art of clinical nursing theory. Quasi experimental approach was 
used with post test only control group design, with 30 samples in 
experimental and control group each. Non probability, purposive 
sampling was used and the study was conducted at Dr.Kamakshi 
Memorial Hospital, Chennai.  
The tool consisted of structured questionnaire to elicit the demographic 
variables and WHO Oral Mucositis Scale was used to assess the level of 
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oral mucositis. The tool was validated by 5 experts and the validity of 
the tool was established. The reliability of the tool was found (r=0.8) by 
test retest method, and the tool was considered as fit for proceeding with 
pilot study. 
          A Pilot study was conducted to assess the feasibility, 
practicability of the study and six patients were selected who fulfilled 
the inclusion criteria, The intervention had an appreciable decrease in 
the level of oral mucositis among patients undergoing chemotherapy.  
          A total number of 60 chemotherapy patients who met the 
inclusion criteria were selected by non probability convenient sampling 
technique. The subjects in first and second week are taken as 
experimental group, the subjects in third and four week are taken as 
control group. 
          After getting the consent, the pomegranate popsicles were given 
to patients in experimental group. Routine hospital measures were 
followed for patients in control group. Post test level of oral mucositis 
was assessed by using the WHO Oral Mucositis Scale on seventh day 
and data was analysed using descriptive and inferential statistics.   
The findings from the post test showed that 23% of patients in 
experimental group developed oral mucositis while 43% of patients in 
control group developed mild and moderate oral mucositis. So the 
incidence of oral mucositis was 20% higher in patients who did not get 
cryotherapy with pomegranate popsicles.  
The analysis revealed that mean and standard deviation of post test level 
of oral mucositis of chemotherapy patients in experimental and control 
group the mean value of 0.23 with SD 0.23 and the mean value of 0.63 
with SD 0.809 of post test level in control group projects „t‟ value as 
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2.392 is statistically significant at p < 0.05 level. Hence the stated 
research Hypothesis (H1) was accepted. 
There was a significant association in post test level of oral mucositis in 
experimental group with what the patients intake of chat items in the 
diet, but there is no association with other demographic variables like 
age, sex, marital status, religion, etc.  Hence the stated research 
Hypothesis (H2) was retained. 
 6.2 CONCLUSION: 
Oral Mucositis is one of the most common side effect of chemotherapy, 
it adversely affects the course of chemotherapy and the patients quality 
of life as well. This study highlighted the effectiveness of Pomegranate 
Popsicles in reducing oral mucositis among chemotherapy patients, and 
thereby improves the quality of life. As popsicles can be made easily 
and is readily available, patients can effectively use this method to 
prevent oral mucositis. Nurses can promote the use of pomegranate 
popsicles, thus promoting the patients quality  of life and prognosis of 
the disease. 
Study findings showed that pomegranate popsicle is a more effective in 
reduction of oral mucositis among patients undergoing chemotherapy is 
a non-pharmacological, cost effective and simple approach in preventing 
oral mucositis 
          6.3 IMPLICATIONS 
This section of the research report that focuses on Nursing implications, 
which includes specific suggestions for Nursing practice, Nursing 
education, Nursing administration and Nursing research.  
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NURSING PRACTICE 
 Oral cooling by cryotherapy is a nursing intervention that is 
well-tolerated by patients and easily implemented by nurses. 
 Nurses should get the co-operation of the diet kitchen team and 
resources in preparation, transportation and use of 
Pomegranate Popsicles. 
 Nurses should create awareness and motivate others in the 
team to use this approach in reducing the oral mucositis among 
chemotherapy patients. 
 Teach the staff nurses about the effectiveness of pomegranate 
popsicles to reduce oral mucositis among chemotherapy 
patients. 
 Nurses can give health education to the patients on oral 
mucositis and how it can be prevented by pomegranate 
popsicles. 
NURSING EDUCATION 
 A Continuing nursing education program can be arranged on 
cryotherapy with popsicles and chemotherapy induced oral 
mucositis. 
 Pomegranate Popsicles is a non pharmacological intervention 
that can be integrated with Nursing curriculum.  
 In service education can be given to staff Nurses and faculty 
members regarding cryotherapy and chemotherapy induced 
oral mucositis. 
 Nursing students from various levels must be educated about 
oral cryotherapy in order to practice in the clinical settings.  
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 A nurse educator should encourage the students for effective 
utilization of research evidence based practice related to 
oral cryotherapy by pomegranate popsicles on 
chemotherapy patients. 
NURSING ADMINISTRATION 
 The Nurse administrator should create awareness of importance 
and benefit of oral cryotherapy with pomegranate popsicles. 
 Oral cryotherapy with pomegranate popsicles is one of the cost 
effective intervention for oral mucositis which develops due to 
chemotherapy, so arrangements can be made for it preparation 
and use in chemotherapy department. 
 Nurse administrators can get the co-operation of the dietitians in 
preparation, storage and transport of popsicles for patients in 
chemotherapy ward. 
 Nurse administrator can instruct and encourage their subordinates 
to utilize this as a nursing intervention in their clinical settings. 
 Arrange and conduct workshop, conference and seminars on oral 
mucositis and its management by oral cryotherapy with 
pomegranate popsicles. 
NURSING RESEARCH 
 As a nurse researcher, promote more research on cryotherapy for 
oral mucositis among chemotherapy patients.  
 Studies related to using frozen fruit juices are rare in Nursing 
field. So the Nurse researcher can conduct similar studies related 
to cryotherapy with other fruit juices. This will help the Nurses to 
promote to Evidence Based Practice in this aspect.  
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 Disseminate the findings of the research through conferences, 
seminars and publishing in nursing journal.  
 Promote effective utilization of research findings on management 
of oral mucositi by cryotherapy with pomegranate popsicles in 
chemotherapy wards. 
6.4 RECOMMENDATIONS 
 The same study can be done with large sample size so that the 
results can be generalized. 
 Comparison of frozen juices for cryotherapy with other types of 
management for chemotherapy induced oral mucositis can be 
conducted. 
 Studies can be conducted to assess the Knowledge and Practice 
of Medical and Paramedical personnel‟s regarding cryotherapy 
with frozen juices. 
 Studies can be conducted to assess the awareness and practice n 
cryotherapy with frozen juices on oral mucositis induced by 
chemotherapy. 
 The same study can be done on different settings on larger 
number of samples. 
 Studies to assess the quality of life improved by pomegranate 
popsicles. 
 Studies can be done to assess effect of pomegranate popsicles on 
continuous three cycles of chemotherapy.  
 A similar study can be done by changing the fruit juice and 
checking the patient‟s preference. 
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6.5 LIMITATIONS 
 The investigator found difficulty in getting adequate literature 
related to the study related to fruit juice oral cryotherapy. 
 The pomegranate popsicles had to be prepared freshly everyday.  
 The investigator faced difficulty in transport of the popsicles.  
 The preparation of pomegranate popsicles was a time consuming 
process. 
 Due to time constrains, the investigator was unable to take large 
samples for the study. 
 Due to time constraint, investigator could not assess other cycle 
of chemotherapy. 
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DEMOGRAPHIC VARIABLES 
Part – I       (GENERAL INFORMATION) 
1. Age in years 
a) 30-39    
b) 40-49 
c) 50-60 
 
2. Sex 
a) Male      
b) Female 
 
3. Marital status. 
a) Married        
b) Unmarried 
c) Widower 
d) Divorced 
 
4. Religion  
a) Hindu         
b) Muslim 
c) Christian 
d) Others 
 
5. Educational status 
a) Un Educated       
b) Primary school 
c) High school 
d) Graduate 
 
6. Occupation 
a) Home Maker        
b) Government 
c) Private 
d) Business 
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7. Type of Activity 
a) Sedentary         
b) Moderate 
c) Heavy 
 
8. Monthly family income 
a) Below Rs.8000/- 
b) Rs.8000 – 10000/- 
c) Rs.10000 – 15,000/- 
d) Above Rs.15,000 
 
9. Does any of your family members have cancer 
a) Yes 
b) No 
 
10. Is any of your family member taking chemotherapy 
a) Yes 
b) No 
 
 
Part II     (ORAL HYGIENE) 
 
11. Do you use mouth wash solution 
a) Yes          
b) No 
 
12. How many times do you brush in a day 
a)  I don‟t brush         
b) Once 
c) Twice 
d) Thrice 
 
13. What do you use for cleaning your teeth? 
a) Tooth Powder        
b) Toothpaste  
c) Charcoal Powder 
d) Chewing Stick 
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14.  How often do you gargle? 
a)  I don‟t gargle       
b) Once a day 
c) Twice a day 
d) Thrice a day 
 
Part III     (DIET) 
 
15. Dietary Pattern 
         a)Vegetarian 
         b)Non-Vegetarian 
 
16. How often do you eat sweets? 
a) Never 
b) everyday 
c) few times a week 
d) few times a month 
 
17.  How often do you include chat items in your diet? 
a) Never 
b) everyday 
c) few times a week 
d) few times a month 
 
18. How often do you have fizzy drinks? 
a)  Never 
b)  everyday 
c) few times a week 
d) few times a month 
 
Part IV     (HABITS) 
 
19. Do you have the habit of chewing tobacco? 
   a)Yes 
   b)No 
 
20. Do you have the habit of smoking or drinking alcohol? 
   a)Yes 
   b)No 
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W.H.O - ORAL MUCOSITIS SCALE 
 
Patient Score: Grade  
 
 
SCORING KEY 
W.H.O - ORAL MUCOSITIS SCALE 
 
 
 
 
 
 
  
 
 
GRADE  DEFINITION 
0 None 
1 Soreness  ± Erythema 
2 Erythema, ulcers, and patient can swallow solid food 
3 
Ulcers with extensive erythema and patient cannot 
swallow solid food 
4  Mucositis to the extent that alimentation is not possible 
GRADE SCORE 
0 None 
1 Mild 
2 Moderate 
3 Severe 
4 
Intravenous 
Feeding 
  78 
POMEGRANATE POPSICLES 
Preparation of Pomegranate Popsicles 
Step1: Selecting the pomegranates. (Punica granatum – Ruby variety) 
                    This variety has small soft seed and medium sized arils. Its                  
                    deep red colour makes it appealing to the patients. 
 
Step2: Deep red pomegranates are washed thoroughly and then peeled.  
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Step3: The grains are separated in a bowl and then put in a blender. 
            They are allowed to blend for 2 seconds. (Blending for 2   
          seconds peals the pulp, extracting the juice but leaving the  
          seeds unbroken. Thus making a fine nectar rather than making  
           the juice whitish and milky.) 
 
Step4: After blending, the juice is filtered with a pimary strainer and 
then a  secondary strainer to remove any fine particles.  
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Step5: The juice is further fine filtered using a jelly bag, leaving 
behind a fine neactar of deep red pomegranate juice.  
 
 
Step6: The juice is then gently poured into the standard ice cube 
maker                  
         of (4x2.5) size. 
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Step8: The ice cube maker is sealed with an aluminiam foil and 7 cm ice 
cream sticks are placed in the center of each cubical space, and kept to 
freez for 2-3 hours. 
 
Step9: Once its frozen the pomegranate popsicles are ready to be 
served to chemotherapy patients. 
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PERMISSION LETTER FROM INSTITUTIONAL ETHICS COMMITTEE  
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PERMISSION LETTER FROM DR.KAMAKSHI MEMORIAL HOSPITAL 
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PERMISSION LETTER FROM DR.KAMAKSHI MEMORIAL HOSPITAL 
 
 
 
  85 
CERTIFICATE OF CONTENT VALIDITY 
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CERTIFICATE OF CONTENT VALIDITY 
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CERTIFICATE OF CONTENT VALIDITY 
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RESEARCH CONSENT FORM-ENGLISH 
 
CONSENT FORM 
 
Here by I Mr./Mrs.____________________________Express my consent 
whole heartedly to be the subject of the study is “A Study To Assess The 
Effectiveness Of Pomegranate Popsicles On Inflammation Of The Oral Mucosa 
Among Patients On Chemotherapy In A Selected Hospital At Chennai.”  
I have been explained about pomegranate popsicles. It has been informed that 
the procedure is not going to cause any harm to me. I understand that all the 
personal information about me will be maintained confidentially and I can 
withdraw from the study at any time where I feel uncomfortable. I am willing 
to participate in your study.  
 
Consent:  
The above information regarding the study has been read by me and has been 
explained to me by the investigator from the Venkateswara Nursing College. 
Having understood the same, I hereby give my consent to participate in the 
study. I affixing my signature to indicate my consent and willingness that I will 
cooperate in this study.  
 
 
Name of the subject:  
 
Signature of the subject:  
 
Date:  
 
Name of the researcher: 
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